Petra Pharma Corporation

États‑Unis d’Amérique

Commandez votre montre hebdomadaire Petra Pharma Corporation
Quantité totale PI 35
Rang # Quantité totale PI 41 593
Note d'activité PI 2,5/5.0    35
Rang # Activité PI 21 522

Brevets

Marques

9 0
10 0
16 0
0
 
Dernier brevet 2025 - Solid dispersions of 6-chloro-3-...
Premier brevet 2018 - Aminopyridine derivatives as pho...

Derniers inventions, produits et services

2025 Invention Solid dispersions of 6-chloro-3-[(1r)-1-[3,6-dimethyl-2-(2- methylindazol-5-yl)-4-oxo-chromen-8-y...
Invention Solid forms of 6-chloro-3-[(1r)-1-[3,6-dimethyl-2-(2-methylindazol-5-yl)-4-oxo-chromen-8-yl]ethox...
Invention (r)-3-(6-chloro-3-((1-(2-cyclopropyl-6-fluoro-3-methyl-4-oxo-4h-chromen-8-yl)ethyl)amino)pyridin-...
2024 Invention Allosteric chromenone inhibitors of phosphoinositide 3-kinase (pi3k) for the treatment of disease...
2023 Invention Targeting allosteric and orthosteric pockets of phosphoinositide 3-kinase (pi3k) for the treatmen...
2022 Invention Allosteric chromenone inhibitors of phosphoinositide 3-kinase (pi3k) for the treatment of cancer....
2018 Invention Aminopyridine derivatives as phosphatidylinositol phosphate kinase inhibitors. 1122, and W are de...
Invention Chromenopyridine derivatives as phosphatidylinositol phosphate kinase inhibitors. The invention r...
Invention Aryl-bipyridine amine derivatives as phosphatidylinositol phosphate kinase inhibitors. 123455, an...